Senaste uppdateringen :
17/12/2025

Sök Sök

Monografi Cyclophosphamide injektioncancerläkemedel Cyclophosphamide (Storbritannien, Förenta Staterna, Saudi-Arabien, nya Zeeland)
ATC : L01AA01
Monografi Cyclophosphamide Oral lösningcancerläkemedel ATC : L01AA01
Monografi Cyclophosphamide Kapselcancerläkemedel ATC : L01AA01
Hänvisningar 40 Pharm Sci Communications Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
Hänvisningar 50 Am J Health-Syst Pharm Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
Hänvisningar 170 Am J Hosp Pharm Effect of briefly heating cyclophosphamide solutions.
Hänvisningar 172 J Parenter Sci Technol Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
Hänvisningar 1728 Pharmazie Stability of cyclophosphamide containing infusions.
Hänvisningar 1833 Ann Pharmacotherapy Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
Hänvisningar 2000 J Pharm Biomed Anal Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
Hänvisningar 2016 Am J Health-Syst Pharm Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
Hänvisningar 3096 Ann Pharmacotherapy Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
Hänvisningar 4865 Dr REDDY laboratoire Cyclophosphamide REDDY PHARMA 2000 mg/4 ML, solution à diluer pour solution injectable/perfusion. - Résumé des caractéristiques du produit.
Hänvisningar 4989 Dr REDDY Extended dilution stability study report of cyclophosphamide concentrate for solution for infusion at room temperature and refrigerated condition ( 2-8°C) - Personal communication - July 2025

  Mentions Légales